FDA approves new antibiotic against UTIs
"The FDA is committed to fostering new antibiotic availability when they prove to be safe and effective, and Pivya will provide an additional treatment option for uncomplicated UTIs," he added. Pivmecillinam has been used in Europe for more than 40 years, where it is typically a first-line therapy for women with uncomplicated UTIs.